221 related articles for article (PubMed ID: 37197794)
1. Prevalence and predictors of tuberculosis infection among people living with HIV in a high tuberculosis burden context.
Njagi LN; Nduba V; Mureithi MW; Mecha JO
BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37197794
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
3. Determinants of QuantiFERON Plus-diagnosed tuberculosis infection in adult Ugandan TB contacts: A cross-sectional study.
Mayito J; Martineau AR; Tiwari D; Nakiyingi L; Kateete DP; Reece ST; Biraro IA
PLoS One; 2023; 18(3):e0281559. PubMed ID: 36972254
[TBL] [Abstract][Full Text] [Related]
4. Practices and attitudes towards tuberculosis and latent tuberculosis infection screening in people living with HIV/AIDS among HIV physicians in Japan.
Kawatsu L; Kaneko N; Imahashi M; Kamada K; Uchimura K
AIDS Res Ther; 2022 Dec; 19(1):60. PubMed ID: 36463211
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
[TBL] [Abstract][Full Text] [Related]
6. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
7. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
8. Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
Uppal A; Rahman S; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003712. PubMed ID: 34520463
[TBL] [Abstract][Full Text] [Related]
9. Positive rate and risk factors of latent tuberculosis infection among persons living with HIV in Jiangsu Province, China.
Zhang Y; Lu P; Wu K; Zhou H; Yu H; Yuan J; Dong L; Liu Q; Lu W; Yang H; Cao D; Zhu L
Front Cell Infect Microbiol; 2023; 13():1051060. PubMed ID: 36960041
[TBL] [Abstract][Full Text] [Related]
10. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
[TBL] [Abstract][Full Text] [Related]
12. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB
BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665
[TBL] [Abstract][Full Text] [Related]
13. Interferon gamma release assays for the diagnosis of latent TB infection in HIV-infected individuals in a low TB burden country.
Cheallaigh CN; Fitzgerald I; Grace J; Singh GJ; El-Eraki N; Gibbons N; Keane J; Rogers TR; Clarke S; Bergin C
PLoS One; 2013; 8(1):e53330. PubMed ID: 23382842
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
[TBL] [Abstract][Full Text] [Related]
15. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
[TBL] [Abstract][Full Text] [Related]
16. Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection.
Petruccioli E; Chiacchio T; Navarra A; Vanini V; Cuzzi G; Cimaglia C; Codecasa LR; Pinnetti C; Riccardi N; Palmieri F; Antinori A; Goletti D
J Infect; 2020 May; 80(5):536-546. PubMed ID: 32097688
[TBL] [Abstract][Full Text] [Related]
17. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of positive IGRAs and innate immune system in HIV-infected individuals in Japan.
Igari H; Takayanagi S; Yahaba M; Tsuyuzaki M; Taniguchi T; Suzuki K
J Infect Chemother; 2021 Apr; 27(4):592-597. PubMed ID: 33386257
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a new interferon gamma release assay, in comparison to tuberculin skin tests and quantiferon tuberculosis goldplus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting.
Benachinmardi K; Sampath S; Rao M
Int J Mycobacteriol; 2021; 10(2):142-148. PubMed ID: 34558465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
